Supreme Court Docket Includes Four Cases Impacting Pharma Industry

Helsinn v. Teva and Merck v. Albrecht directly involve pharma firms while another case addresses America Invents Act. Solicitor General to weigh in on two other cases. Petitions pending on Maryland pricing law, Amgen PCSK9 suit.

Supreme Court long shot

The US Supreme Court is set to hear several pharma-related cases for the term that began Oct. 1. Drug makers are parties in two cases: one involving the on-sale bar to patentability and the other concerning failure-to-warn claims in product liability litigation. Two other cases could also impact the industry: a dispute over the application of the America Invents Act and a case involving class action certification and the deadline for filing an appeal.

The high court has denied several pharma petitions in the past month, while others have recently been filed. It also...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legal & IP

More from Pink Sheet